Literature DB >> 33725896

Cronkhite-Canada syndrome associated with perianal condyloma acuminatum with malignant transformation: A case report.

Wei Wang1, Xian-Yong Cheng, Feng Xue, Hai-Yan Liu, Hai-Feng Lian, Cheng-Xia Liu.   

Abstract

RATIONALE: Cronkhite-Canada syndrome (CCS) is a rare non-familial polyposis syndrome characterized by multiple gastrointestinal polyps with the ectodermal triad. To date, many complications of CCS have been reported in the literature, but perianal condyloma acuminatum with malignant transformation has not been included. PATIENT CONCERNS: This report presents the case of a 52-year-old Chinese man who presented with diarrhea, loss of appetite, and weight loss. He developed skin pigmentation and atrophy of the fingernails and toenails. Upper gastrointestinal endoscopy, colonoscopy, capsule endoscopy, and enteroscopy revealed diffuse polyps along the entire digestive tract. Histopathological examination revealed polyps of different pathological types dominated by hamartoma. Physical examination revealed a crissum cauliflower-like neoplasm (2.5 × 2.0 cm). After perianal tumor resection, pathology suggested that this was a perianal condylomatous lesion with malignant transformation, as well as well-differentiated squamous cell carcinoma. DIAGNOSES: These clinical features and endoscopic findings were consistent with CCS which associated with perianal condyloma acuminatum with malignant transformation. INTERVENTION: Clinical remission was achieved with glucocorticoid, azathioprine, and nutritional support. OUTCOME: At the 4-year follow-up, the patient had no diarrhea or loss of appetite, had gained 13 kg in weight, and the perianal tumor had not recurred. LESSONS: No previous report has described CCS in a patient with perianal condyloma acuminatum with malignant transformation. As both conditions are related to immune disorders, their occurrence may be correlated.
Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33725896      PMCID: PMC7969240          DOI: 10.1097/MD.0000000000025067

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.817


  14 in total

1.  Generalized gastrointestinal polyposis; an unusual syndrome of polyposis, pigmentation, alopecia and onychotrophia.

Authors:  L W CRONKHITE; W J CANADA
Journal:  N Engl J Med       Date:  1955-06-16       Impact factor: 91.245

2.  Clinicopathologic features and treatment outcomes in Cronkhite-Canada syndrome: support for autoimmunity.

Authors:  Seth Sweetser; David A Ahlquist; Neal K Osborn; Schuyler O Sanderson; Thomas C Smyrk; Suresh T Chari; Lisa A Boardman
Journal:  Dig Dis Sci       Date:  2011-09-01       Impact factor: 3.199

3.  Small-bowel video capsule endoscopic findings of Cronkhite-Canada syndrome.

Authors:  Timothée Wallenhorst; Mael Pagenault; Guillaume Bouguen; Laurent Siproudhis; Jean-François Bretagne
Journal:  Gastrointest Endosc       Date:  2016-04-18       Impact factor: 9.427

4.  [Clinicopathologic features of Cronkhite-Canada syndrome and the significance of IgG4-positive plasma cells infiltration].

Authors:  Y Li; H Q Luo; D Wu; X W Xue; Y F Luo; Y M Xiao; J Chen; W X Zhou
Journal:  Zhonghua Bing Li Xue Za Zhi       Date:  2018-10-08

5.  Cronkhite Canada Syndrome: Significant Response to Infliximab and a Possible Clue to Pathogenesis.

Authors:  Brigid S Boland; Preet Bagi; Mark A Valasek; John T Chang; Ranier Bustamante; Lisa Madlensky; William J Sandborn; Olivier Harismendy; Samir Gupta
Journal:  Am J Gastroenterol       Date:  2016-05       Impact factor: 10.864

Review 6.  Cronkhite–Canada syndrome six decades on: the many faces of an enigmatic disease.

Authors:  Tomas Slavik; Elizabeth Anne Montgomery
Journal:  J Clin Pathol       Date:  2014-10       Impact factor: 3.411

7.  Cronkhite-Canada Syndrome: Sustained Clinical Response with Anti-TNF Therapy.

Authors:  S A Taylor; J Kelly; D E Loomes
Journal:  Case Rep Med       Date:  2018-07-02

8.  Case report of patient with a Cronkhite-Canada syndrome: sustained remission after treatment with corticosteroids and mesalazine.

Authors:  Sigrid Schulte; Fabian Kütting; Jessica Mertens; Thomas Kaufmann; Uta Drebber; Dirk Nierhoff; Ulrich Töx; Hans-Michael Steffen
Journal:  BMC Gastroenterol       Date:  2019-02-27       Impact factor: 3.067

9.  Cronkhite-Canada syndrome: a case report and review of literature.

Authors:  Kevin T Kao; Jitesh K Patel; Vijayamalini Pampati
Journal:  Gastroenterol Res Pract       Date:  2009-08-25       Impact factor: 2.260

10.  Innovative video capsule endoscopy for detection of ubiquitously elongated small intestinal villi in Cronkhite-Canada syndrome.

Authors:  Hauke Sebastian Heinzow; Wolfram Domschke; Tobias Meister
Journal:  Wideochir Inne Tech Maloinwazyjne       Date:  2013-06-18       Impact factor: 1.195

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.